SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. [2395.T]
TOKYO, Apr 30 (Pulse News Wire) – Shin Nippon Biomedical Laboratories,ltd. (2395.T) announced today that its board of directors has decided to appoint Hiroyuki Hirama as the new president effective June 26, 2026.
Ryoi Nagata, currently serving as chairman and president, will transition to chairman solely. Additionally, the company outlined several executive appointments and promotions set to take effect on June 1, 2026, including Kazuhisa Tsunehara becoming a director and Ken Nakahara being appointed as an executive officer.
The official appointments will be finalized during the shareholders' meeting scheduled for June 26, 2026. Hiroyuki Hirama’s detailed resume, which includes his tenure at Mizuho Financial Group and subsequent roles within the company and external organizations, is available in the attached document.
He joined SHIN NIPPON BIOMEDICAL in 2004 and was elected as an executive officer in January 2011, holding 1,000 shares of the company stock.
🟡 Confidence: Standard AI-translated content.